Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia.
BACKGROUND
Purine catabolism may be an unappreciated, but important component of the homeostatic response of mitochondria to oxidant stress. Accumulating evidence suggests a pivotal role of oxidative stress in schizophrenia pathology.


RESULTS
Using high-pressure liquid chromatography coupled with a coulometric multi-electrode array system, we compared 6 purine metabolites simultaneously in plasma between first-episode neuroleptic-naïve patients with schizophrenia (FENNS, n = 25) and healthy controls (HC, n = 30), as well as between FENNS at baseline (BL) and 4 weeks (4w) after antipsychotic treatment. Significantly higher levels of xanthosine (Xant) and lower levels of guanine (G) were seen in both patient groups compared to HC subjects. Moreover, the ratios of G/guanosine (Gr), uric acid (UA)/Gr, and UA/Xant were significantly lower, whereas the ratio of Xant/G was significantly higher in FENNS-BL than in HC. Such changes remained in FENNS-4w with exception that the ratio of UA/Gr was normalized. All 3 groups had significant correlations between G and UA, and Xan and hypoxanthine (Hx). By contrast, correlations of UA with each of Xan and Hx, and the correlation of Xan with Gr were all quite significant for the HC but not for the FENNS. Finally, correlations of Gr with each of UA and G were significant for both HC and FENNS-BL but not for the FENNS-4w.


CONCLUSIONS
During purine catabolism, both conversions of Gr to G and of Xant to Xan are reversible. Decreased ratios of product to precursor suggested a shift favorable to Xant production from Xan, resulting in decreased UA levels in the FENNS. Specifically, the reduced UA/Gr ratio was nearly normalized after 4 weeks of antipsychotic treatment. In addition, there are tightly correlated precursor and product relationships within purine pathways; although some of these correlations persist across disease or medication status, others appear to be lost among FENNS. Taken together, these results suggest that the potential for steady formation of antioxidant UA from purine catabolism is altered early in the course of illness.
Yao
Jeffrey K
JK
VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States of America. jkyao@pitt.edu
Dougherty
George G
GG
Reddy
Ravinder D
RD
Keshavan
Matcheri S
MS
Montrose
Debra M
DM
Matson
Wayne R
WR
McEvoy
Joseph
J
Kaddurah-Daouk
Rima
R
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000494:pharmacology*; D016022:Case-Control Studies; D004032:Diet; D005260:Female; D006151:Guanosine / Q000737:chemistry; D006706:Homeostasis; D006801:Humans; D019271:Hypoxanthine / Q000737:chemistry; D008297:Male; D008660:Metabolism; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D011687:Purines / Q000737:chemistry*; D012263:Ribonucleosides / Q000737:chemistry; D012559:Schizophrenia / Q000097:blood* / Q000378:metabolism; D012907:Smoking; D014527:Uric Acid / Q000737:chemistry; D014970:Xanthines
D014150:Antipsychotic Agents; D011687:Purines; D012263:Ribonucleosides; D014970:Xanthines; D006151:Guanosine; D014527:Uric Acid; D019271:Hypoxanthine; C005893:xanthosine